GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Beneish M-Score

Gerresheimer AG (XTER:GXI) Beneish M-Score : -2.78 (As of May. 21, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.78 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Gerresheimer AG's Beneish M-Score or its related term are showing as below:

XTER:GXI' s Beneish M-Score Range Over the Past 10 Years
Min: -3.05   Med: -2.63   Max: -2.26
Current: -2.78

During the past 13 years, the highest Beneish M-Score of Gerresheimer AG was -2.26. The lowest was -3.05. And the median was -2.63.


Gerresheimer AG Beneish M-Score Historical Data

The historical data trend for Gerresheimer AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Beneish M-Score Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.65 -2.85 -2.60 -2.44 -2.74

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.38 -2.52 -2.74 -2.74 -2.78

Competitive Comparison of Gerresheimer AG's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's Beneish M-Score falls into.



Gerresheimer AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gerresheimer AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9512+0.528 * 1.0272+0.404 * 0.9083+0.892 * 1.0498+0.115 * 1.1103
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9667+4.679 * -0.073111-0.327 * 0.8444
=-2.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb24) TTM:Last Year (Feb23) TTM:
Total Receivables was €297 Mil.
Revenue was 466.138 + 545.17 + 487.94 + 499.604 = €1,999 Mil.
Gross Profit was 129.593 + 159.315 + 149.831 + 154.115 = €593 Mil.
Total Current Assets was €865 Mil.
Total Assets was €3,469 Mil.
Property, Plant and Equipment(Net PPE) was €1,295 Mil.
Depreciation, Depletion and Amortization(DDA) was €189 Mil.
Selling, General, & Admin. Expense(SGA) was €326 Mil.
Total Current Liabilities was €973 Mil.
Long-Term Debt & Capital Lease Obligation was €651 Mil.
Net Income was 13.008 + 41.617 + 28.026 + 34.434 = €117 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = €0 Mil.
Cash Flow from Operations was 27.259 + 149.363 + 158.921 + 35.178 = €371 Mil.
Total Receivables was €298 Mil.
Revenue was 457.772 + 528.708 + 472.97 + 444.619 = €1,904 Mil.
Gross Profit was 134.053 + 159.917 + 148.79 + 137.339 = €580 Mil.
Total Current Assets was €831 Mil.
Total Assets was €3,263 Mil.
Property, Plant and Equipment(Net PPE) was €1,076 Mil.
Depreciation, Depletion and Amortization(DDA) was €177 Mil.
Selling, General, & Admin. Expense(SGA) was €321 Mil.
Total Current Liabilities was €960 Mil.
Long-Term Debt & Capital Lease Obligation was €850 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(297.274 / 1998.852) / (297.711 / 1904.069)
=0.148722 / 0.156355
=0.9512

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(580.099 / 1904.069) / (592.854 / 1998.852)
=0.304663 / 0.296597
=1.0272

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (865.208 + 1294.653) / 3469.201) / (1 - (831.446 + 1075.836) / 3263.277)
=0.377418 / 0.415532
=0.9083

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1998.852 / 1904.069
=1.0498

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(176.804 / (176.804 + 1075.836)) / (188.553 / (188.553 + 1294.653))
=0.141145 / 0.127125
=1.1103

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(325.662 / 1998.852) / (320.898 / 1904.069)
=0.162925 / 0.168533
=0.9667

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((651.36 + 973.199) / 3469.201) / ((849.727 + 959.985) / 3263.277)
=0.46828 / 0.554569
=0.8444

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(117.085 - 0 - 370.721) / 3469.201
=-0.073111

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gerresheimer AG has a M-score of -2.78 suggests that the company is unlikely to be a manipulator.


Gerresheimer AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines